Autoimmunity to chondrocyte-producing
proteins has been reported in patients with
osteoarthritis (OA) as well as in those with
rheumatoid arthritis (RA). To answer whether or not OA-specific autoimmunity exist, we performed screening of chondrocyte-producing
autoantigens by two-dimensional electrophoresis and Western blotting with each of 20 OA and 20 RA serum samples. We identified an apparently OA-specific
autoantigen spot with a molecular mass of 52 kDa and a Isoelectric point of 4.1 as fibulin-4 by mass fingerprinting. By preparing
recombinant proteins of fibulin-4, we determined prevalence of the
autoantibodies to fibulin-4 in 92 patients with OA, 67 patients with RA, 40 patients with
systemic lupus erythematosus, and 43 patients with
systemic scleroderma. As a result, the
IgG type anti-fibulin-4
autoantibodies were detected in 23.9% of sera from patients with OA, in 8.9% of sera from patients with RA, in 2.5% of sera from patients with
systemic lupus erythematosus, and in 9.3% of sera from patients with
systemic scleroderma. Furthermore, we immunized DBA/1J, ICR, BALB/c, and C57BL/6 mice with the recombinant fibulin-4
proteins to investigate arthritogenecity of fibulin-4. As a result, mild
synovitis was detected in all of the four strains. In addition, we demonstrated expression of fibulin-4 in chondrocytes at both
mRNA and
protein levels in vivo and in vitro by RT-PCR, Western blotting, and immunohistochemistry. Taken together, fibulin-4, expressed in chondrocytes and recognized as an
autoantigen mainly in OA rather than in RA, may play pathogenic roles in OA.